Compared with patients with CK19-negative HCCs, CK19-positive HCCs is associated with clinical aggressiveness due to more tumor invasion, higher rate of lymph node metastasis intrahepatic recurrence, and poorer prognosis after resection and liver transplantation (6, 7). Here, KRT19 is linked to metastatic malignant neoplasm in the lymph nodes.